Premium
Dimethyl fumarate for the treatment of plaque psoriasis
Author(s) -
Chaplin Steve
Publication year - 2018
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1643
Subject(s) - medicine , dimethyl fumarate , plaque psoriasis , psoriasis , dermatology , adverse effect , immunology , multiple sclerosis
Dimethyl fumarate (Skilarence) is an oral therapy licensed for the treatment of moderate to severe plaque psoriasis in adults when systemic treatment is indicated. This article discusses its efficacy, adverse effects and place in therapy.